£1.5M
SCVC led the pre-seed round with backing from Deep Science Ventures and Cambridge Enterprise VC to help the startup expand its team and partnerships.
Houdini Bio develops software that redesigns therapeutic DNA so the body does not attack it.
Cambridge-based biotechnology startup developing software that redesigns therapeutic DNA to prevent cellular silencing. The firm uses machine learning to improve gene therapy durability and performance.
Lee Dunham
Chief Business Officer
SCVC led the pre-seed round with backing from Deep Science Ventures and Cambridge Enterprise VC to help the startup expand its team and partnerships.